Effects of Vaccination and Previous Infection on Omicron Infections in Children.
- Resource Type
- letter
- Authors
- Dan-Yu Lin; Yu Gu; Yanglianchen Xu; Lin, Dan-Yu; Gu, Yu; Xu, Yangjianchen; Zeng, Donglin; Wheeler, Bradford; Young, Hayley; Sunny, Shadia Khan; Moore, Zack
- Source
- New England Journal of Medicine. 9/22/2022, Vol. 387 Issue 12, p1141-1143. 3p.
- Subject
- *SARS-CoV-2 Omicron variant
*CORONAVIRUS diseases
*VACCINATION
*IMMUNIZATION
- Language
- ISSN
- 0028-4793
An editorial is presented on the Food and Drug Administration authorized the BNT162b2 vaccine (Pfizer–Biotech) for emergency use in children 5 to 11 years of age, on the basis of an immunobridging study and a small efficacy study. Topics include on the protection conferred by the BNT162b2 vaccine and by previous SARS-CoV-2 infection against infection and coronavirus disease 2019 (Covid-19)–related hospitalization and death in children 5 to 11 years of age.